On Tuesday, Gossamer Bio Inc (NASDAQ: GOSS) was 11.24% up from the session before settling in for the closing price of $1.74. A 52-week range for GOSS has been $0.66 – $2.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 40.29% over the past five years. When this article was written, the company’s average yearly earnings per share was at -167.09%. With a float of $182.73 million, this company’s outstanding shares have now reached $227.32 million.
Let’s look at the performance matrix of the company that is accounted for 145 employees. In terms of profitability, gross margin is 71.45%, operating margin of -361.91%, and the pretax margin is -353.62%.
Gossamer Bio Inc (GOSS) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Gossamer Bio Inc stocks. The insider ownership of Gossamer Bio Inc is 19.64%, while institutional ownership is 59.81%.
Gossamer Bio Inc (GOSS) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.14 earnings per share (EPS) during the time that was better than consensus figure (set at -0.14) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -167.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.92% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
You can see what Gossamer Bio Inc (GOSS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Gossamer Bio Inc (NASDAQ: GOSS) saw its 5-day average volume 3.1 million, a positive change from its year-to-date volume of 1.94 million. As of the previous 9 days, the stock’s Stochastic %D was 25.37%.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 79.59%, which indicates a significant increase from 46.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1865 in the past 14 days, which was higher than the 0.1134 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5318, while its 200-day Moving Average is $1.1342. Nevertheless, the first resistance level for the watch stands at $2.0050 in the near term. At $2.0800, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2100. If the price goes on to break the first support level at $1.8000, it is likely to go to the next support level at $1.6700. Assuming the price breaks the second support level, the third support level stands at $1.5950.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
There are 227,381K outstanding shares of the company, which has a market capitalization of 438.84 million. As of now, sales total 114,700 K while income totals -56,530 K. Its latest quarter income was 11,490 K while its last quarter net income were -38,270 K.